LINC00115 was identified as a novel regulator of chemotherapy-resistant breast cancer stem-like cells and high LINC00115 expression is linked to a poor prognosis in breast cancer patients post-chemotherapy (42). Here, LINC00115 is linked to breast carcinoma.